Global Remicade Biosimilar Market Report By Disease Indication (Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Psoriatic Arthritis And Plaque Psoriasis) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210446
February 2019
Report Formats:
As per this study the Global Remicade Biosimilar Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.
Biosimilar refers to biopharmaceutical drug, which resembles the existing licensed therapeutic drug in terms of quality, efficiency and safety. Remicade is the commercially available brand name of infliximab. Infliximab is the chimeric monoclonal antibody biologic drug used to treat autoimmune diseases such as treat rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis (a type of spinal arthritis), psoriatic arthritis, and the red, scaly skin patches of plaque psoriasis. Biosimilar for remicade are inflectra, renflexis, remsima and flixabi.
Market Dynamics
Rising market competitiveness resulting into a decline in the prices of biosimilar products is driving the market growth. Use of biosimilar products to improve patients’ access to medicine by offering financial relief is further fueling the market growth. Also, growing healthcare expenditure followed by a rise in the prevalence of autoimmune medical conditions is again boosting the market demand. However, serious side effects followed by stringent regulatory guidelines for the development of these biosimilar drugs may hinder the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of remicade biosimilar.
Market Segmentation
The broad remicade biosimilar market has been sub-grouped into disease indication. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Disease Indication
- Ulcerative Colitis
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Crohn’s Disease
- Psoriatic Arthritis
- Plaque Psoriasis
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for remicade biosimilar in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Remicade Biosimilar Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the remicade biosimilar market include Alvogen, Celltrion, Janssen Biotech, Inc., Merck and Company, Inc., Napp Pharmaceuticals, Nippon Kayaku and Pfizer, Inc. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
1. INTRODUCTION
- Introduction To Remicade Biosimilar
- Report Description
- Objectives Of The Study
- Assumptions
- Research Scope
- Research Methodology
- Data Source
2. EXECUTIVE SUMMARY
- Market Highlight
- Global Remicade Biosimilar Market: Snapshot
3. MARKET ANALYSIS
- Drivers
- Restraints
- Opportunities
- Porter’s Five Forces Analysis
- Value Chain Analysis
4. REMICADE BIOSIMILAR MARKET ANALYSIS BY DISEASE INDICATION
- Market In Ulcerative Colitis
- Market In Rheumatoid Arthritis
- Market In Ankylosing Spondylitis
- Market In Crohn’s Disease
- Market In Psoriatic Arthritis
- Market In Plaque Psoriasis
5. REMICADE BIOSIMILAR MARKET ANALYSIS BY GEOGRAPHY
- North America (NA)
- North America Market Estimates
- North America Market Estimates By Country
- United States (U.S.) Market Estimates By Segments
- Rest Of North America Market Estimates By Segments
- Europe (EU)
- Europe Market Estimates
- Europe Market Estimates By Country
- United Kingdom (UK) Market Estimates By Segments
- Germany Market Estimates By Segments
- France Market Estimates By Segments
- Rest Of Europe Market Estimates By Segments
- Asia Pacific (APAC)
- Asia Pacific Market Estimates
- Asia Pacific Market Estimates By Country
- China Market Estimates By Segments
- Japan Market Estimates By Segments
- India Market Estimates By Segments
- Rest Of Asia Pacific Market Estimates By Segments
- Latin America (LA)
- Latin America Market Estimates
- Latin America Market Estimates By Country
- Brazil Market Estimates By Segments
- Rest Of Latin America Market Estimates By Segments
- Middle East And Africa (MEA)
- Middle East And Africa Market Estimates
- Middle East And Africa Market Estimates By Country
- Middle East Market Estimates By Segments
- Africa Market Estimates By Segments
6. COMPETITIVE LANDSCAPE OF THE REMICADE BIOSIMILAR COMPANIES
- Market Competition
- Partnerships/Collaborations/Agreements
- Mergers And Acquisitions
- New Product Launches
- Other Developments
7. COMPANY PROFILES OF THE REMICADE BIOSIMILAR INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
- Alvogen
- Celltrion
- Janssen Biotech, Inc.
- Merck and Company, Inc.
- Napp Pharmaceuticals
- Nippon Kayaku
- Pfizer, Inc.
* Tentative TOC
LIST OF TABLES
Table 1. Market Highlights Of Remicade Biosimilar
Table 2. Global Remicade Biosimilar Market By Disease Indication
Table 3. Global Remicade Biosimilar Market By Geography
Table 4. North America Remicade Biosimilar Market
Table 5. Europe Remicade Biosimilar Market
Table 6. Asia Pacific Remicade Biosimilar Market
Table 7. Latin America Remicade Biosimilar Market
Table 8. Middle East And Africa Remicade Biosimilar Market
Table 9. Partnership/Collaboration/Agreements
Table 10. Mergers And Acquisitions
Table 11. New Product Development
Table 12. Other Developments
LIST OF FIGURES
Fig. 1. Market Segmentation Of Remicade Biosimilar Market
Fig. 2. Top-Down Approach
Fig. 3. Bottom-Up Approach
Fig. 4. Market Highlights Of Remicade Biosimilar
Fig. 5. Porter’s Five Forces Analysis
Fig. 6. Value Chain Analysis
Fig. 7. Global Remicade Biosimilar Market By Disease Indication
Fig. 8. Global Remicade Biosimilar Market By Geography
Fig. 9. North America Remicade Biosimilar Market
Fig. 10. Europe Remicade Biosimilar Market
Fig. 11. Asia Pacific Remicade Biosimilar Market
Fig. 12. Latin America Remicade Biosimilar Market
Fig. 13. Middle East And Africa Remicade Biosimilar Market
Fig. 14. Market Share Of Remicade Biosimilar Companies
Fig. 15. Recent Developments In Remicade Biosimilar Industry
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
